PRILOCAINE

Gout

Express Specialty PharmacySmall moleculeDormant

D

30/ 100

Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence: 15/ 100
Competitive Position: 89/ 100

Competitive context

5 Active assets in the Gout cohort.

Asset / Sponsor	Phase	Rating
Febuxostat Haiphong University of Medicine and Pharmacy	Phase 4	BBB
Allopurinol Haiphong University of Medicine and Pharmacy	Phase 4	B
Metformin Mostafa Bahaa	Phase 2	CCC
Abp-745 Atom Therapeutics Co., Ltd	Phase 1	CC
Treximet® Express Specialty Pharmacy		D

View all 19 →

Same molecule, other indications

PRILOCAINE is also rated in:

Leukemia-LymphomaDormant

BB

Indicative ·

69 / 100

Migraine DisordersDormant

BB

Indicative ·

64 / 100

Non Hodgkin LymphomaDormant

B

Indicative ·

62 / 100

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.